Watertown, MA, United States of America

Alexandros Makriyannis

USPTO Granted Patents = 57 

 

 

Average Co-Inventor Count = 2.8

ph-index = 13

Forward Citations = 512(Granted Patents)

Forward Citations (Not Self Cited) = 253(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Willimantic, CT (US) (2000)
  • Ashford, CT (US) (1995 - 2003)
  • Mystic, CT (US) (2005 - 2010)
  • Boston, MA (US) (2006 - 2018)
  • Watertown, MA (US) (2005 - 2024)

Company Filing History:


Years Active: 1995-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cannabinergic Compounds
FAAH Inhibitors
MAGL Inhibitors
N-acylethanolamine Hydrolyzing Acid Amidase
Cannabinoid Receptor Antagonists
Bicyclic Cannabinoids
Cannabimimetic Ligands
Pyrazole Derivatives
Peripheral Cannabinoid Receptor
Therapeutic Applications
Analgesic Cannabinoids
Antiprotozoal Phospholipids
57 patents (USPTO):Explore Patents

Title: The Innovative Journey of Alexandros Makriyannis

Introduction: Alexandros Makriyannis, a pioneering inventor based in Watertown, MA (US), has made significant contributions to the field of pharmaceuticals and drug discovery.

Latest Patents: Makriyannis holds several patents in the area of medicinal chemistry and pharmacology, focusing on novel compounds for the treatment of various diseases such as cancer, neurological disorders, and chronic pain.

Career Highlights: With a distinguished career spanning over several decades, Makriyannis has served as a professor at Northeastern University and the Director of the Center for Drug Discovery. He has been instrumental in leading groundbreaking research projects that have led to the development of innovative drugs and therapies.

Collaborations: Throughout his career, Makriyannis has collaborated with leading pharmaceutical companies, research institutions, and fellow inventors to advance the field of drug discovery. His collaborative efforts have resulted in the successful translation of research findings into practical applications for patient care.

Conclusion: Alexandros Makriyannis continues to be a driving force in the world of pharmaceutical innovation, with his groundbreaking work paving the way for the development of new and improved treatments for a wide range of medical conditions. His dedication to scientific excellence and commitment to improving global health make him a true visionary in the field of drug discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…